Literature DB >> 21658115

Risk factors for recurrence of scabies: a retrospective study of scabies patients in a long-term care hospital.

Kuniko Makigami1, Noriko Ohtaki, Norihisa Ishii, Tetsuko Tamashiro, Sadao Yoshida, Seiji Yasumura.   

Abstract

A considerable number of patients suffer recurrence of scabies. To elucidate risk factors for recurrence of scabies, we compared patients who experienced scabies recurrence and those who suffered scabies only once. We conducted a retrospective review of medical records of all scabies patients in a long-term care hospital for the elderly (300 beds; six wards) for a period of 42 months to determine frequency of scabies onsets, underlying diseases, history of treatment, and demographic data such as age and sex. One hundred and forty-eight patients and five hospital staff members suffered scabies during the 42-month study period. All staff members and 98 patients had no recurrence, while 50 patients experienced at least one recurrence of scabies. The cumulative number of scabies diagnoses was 228. The rates of scabies onset and recurrence were considerably different among wards. The dementia unit showed the highest rate of onset and recurrence. In addition to frequent exposure to infectious sources, problematic behavior, such as lying in other patients beds, might cause the high recurrence rate in dementia units. Higher serum total lymphocyte count and topical use of γ-benzene hexachloride were associated with lower risk of scabies recurrence. Recurrence of scabies is not uncommon among elderly patients in institutional settings. Impaired immunity may be a risk factor for recurrence of scabies. Groups with a high onset rate of scabies pose a high likelihood of recurrence. Problematic behavior of demented patients may increase the risk of recurrence. Use of effective topical treatment may effectively prevent recurrence.
© 2011 Japanese Dermatological Association.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21658115     DOI: 10.1111/j.1346-8138.2011.01199.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  7 in total

1.  Diagnosis, prevention, and treatment of scabies.

Authors:  Luis Shimose; L Silvia Munoz-Price
Journal:  Curr Infect Dis Rep       Date:  2013-10       Impact factor: 3.725

Review 2.  Retrospective analysis of institutional scabies outbreaks from 1984 to 2013: lessons learned and moving forward.

Authors:  K E Mounsey; H C Murray; M King; F Oprescu
Journal:  Epidemiol Infect       Date:  2016-03-28       Impact factor: 4.434

3.  Rate and factors for scabies recurrence in children in Saudi Arabia: a retrospective study.

Authors:  Anwar E Ahmed; Hoda Jradi; Doaa A AlBuraikan; Bashayr I ALMuqbil; Monirah A Albaijan; Ali M Al-Shehri; Hamdan Al-Jahdali
Journal:  BMC Pediatr       Date:  2019-06-08       Impact factor: 2.125

4.  Clinical presentation and risk factors of increased scabies cases in the Western region of Saudi Arabia in 2016-2018.

Authors:  Mohammed Wasil A Jastaniah; Ziad Faisal K Zimmo; Mazen Waleed S Bakallah; Mohannad Saeed S Hantoush; Mohammed Abdal-Aziz
Journal:  Saudi Med J       Date:  2019-08       Impact factor: 1.484

5.  Recurrence of Classic Scabies in a Patient Who had Unchanged Tie String of the T-Cannula.

Authors:  Jiwon Jung; Jihye Jeong; Min Jee Hong; Eun Ok Kim; Min Jae Kim; Sung Eun Chang; Sung-Han Kim
Journal:  Infect Chemother       Date:  2021-12-02

6.  Recurrence rate of scabies in patients 14 years or older in Saudi Arabia.

Authors:  Anwar E Ahmed; Hamdan Al-Jahdali; Hoda Jradi; Bashayr I ALMuqbil; Doaa A AlBuraikan; Monirah A Albaijan; Yosra Z Ali; Ali M Al Shehri
Journal:  Saudi Med J       Date:  2019-12       Impact factor: 1.484

7.  MRSA Femoral Osteomyelitis from Superinfected Scabies Lesions: A Pediatric Case Report.

Authors:  Marco Ugo Andrea Sartorio; Alice Marianna Munari; Patrizia Carlucci; Paola Erba; Valeria Calcaterra; Valentina Fabiano
Journal:  Int J Environ Res Public Health       Date:  2022-01-17       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.